GLP-1 Drugs Pick Up Another Win, This Time in Psoriatic Arthritis

(MedPage Today) — DENVER — Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis (PsA) and overweight or obesity, a phase III randomized trial showed.
After 36 weeks, almost a third…